Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial

Published:2019-08 Issue:10200 Volume:394 Page:737-745
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Croop Robert,Goadsby Peter J,Stock David A,Conway Charles M,Forshaw Micaela,Stock Elyse G,Coric Vladimir,Lipton Richard B

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016;Lancet,2017

2. Current practice and future directions in the prevention and acute management of migraine;Goadsby;Lancet Neurol,2010

3. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials;Ferrari;Lancet,2001

4. Framingham-based cardiovascular risk estimates among people with episodic migraine in the US population: results from the American Migraine Prevalence and Prevention (AMPP) study;Lipton;Headache,2017

5. Acute migraine therapy: do doctors understand what patients with migraine want from therapy?;Lipton;Headache,1999

Cited by 268 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rimegepant and atogepant: novel drugs providing innovative opportunities in the management of migraine;Expert Review of Neurotherapeutics;2024-09-12

2. Migraine Treatment: When, Why, and How to Introduce Antimigraine Therapies;The Journal for Nurse Practitioners;2024-09

3. International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine;Cephalalgia;2024-09

4. Cost-effectiveness analysis of rimegepant for on-demand acute treatment of migraine in China;Frontiers in Neurology;2024-08-23

5. Evidence‐based review and frontiers of migraine therapy;Neurogastroenterology & Motility;2024-08-12